Rion found that culturing stem cells in a lab to force division leads to rapid DNA damage, as cells are not designed for this artificial environment. This damage created inconsistent exosome products, making large-scale, uniform manufacturing from stem cells unfeasible and prompting a search for a more stable source.

Regenexx's gene therapy program was halted after its AAV vector integrated into a patient's genome, likely causing a tumor. While AAVs are designed to avoid this, the event puts a spotlight on the known, but rare, risk of insertional mutagenesis for the entire AAV field.

Standard post-thaw viability tests are misleading for cell therapies. DMSO can cause profound, non-lethal damage by altering gene expression, inducing differentiation in stem cells, and impairing T-cell function. Cells may be 'alive' but therapeutically impotent, a risk not captured by simple viability metrics.

Many blood cancers are better understood as "regulatory problems" driven by epigenetic failures—the systems controlling which genes are turned on or off. This shifts the therapeutic focus from targeting DNA mutations to developing drugs, like IDH inhibitors, that correct these underlying control mechanisms.

Despite known toxicity and FDA concerns, DMSO remains the standard cryopreservative because of its extensive clinical history and the high cost required to validate alternatives. Established protocols, regulatory history, and economic advantages create a significant barrier to innovation, trapping the industry in a legacy solution.

A baby's exposure to high glucose levels in the womb can switch on genes related to diabetes. This epigenetic programming significantly increases their risk of developing the disease as an adult, independent of their later lifestyle or genetics.

Germ cell tumors are extremely sensitive to chemotherapy due to intrinsic biological factors, not the immune environment. Their DNA is relatively hypomethylated, leaving it more open to damage, and they have intact apoptosis mechanisms with low rates of P53 mutation. This explains why they respond so well to chemo but poorly to traditional checkpoint inhibitors.

Your DNA is the fixed hardware, but DNA methylation is the dynamic software controlling which genes are expressed. This 'operating system' is constantly updated by lifestyle factors like stress and pollution, making it a key target for influencing health outcomes without changing the underlying genetic code.

Sirtuins are enzymes that regulate gene expression, essentially telling a cell what to be. As DNA damage accumulates with age, they increasingly leave their primary posts to act as a repair crew. This distraction causes the cell to lose its identity and function, creating a direct mechanism for aging.